Look behind the lecture: employing real-world evidence in label expansion

In this interview, Miriam Fenton (Sanofi Genzyme, MA, USA) discusses her presentation from the 3rd Real-World Evidence Forum (15–16 July, PA, USA) on the importance and implications of real-world evidence (RWE) in label expansion. Please can you introduce yourself and your institution? I am a Director of Real-World Evidence (RWE) at Sanofi (Paris, France). Our RWE group sits within the Chief Medical Office and I am situated within Sanofi Genzyme (MA, USA), our specialty care unit. I am the RWE Lead for multiple sclerosis and dermatology, and I also lead our PhD RWE internship program. I have a bachelor’s degree...